Pulmonary hypertension Flashcards

(36 cards)

1
Q

What is the definition of pulmonary hypertension in people?

A

mean pulmonary arterial pressure (PAP) ≥ 25 mm Hg at rest measured invasively by right heart catheterization.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is pulmonary hypertension?

A

abnormally increased pressure within the pulmonary vasculature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 hemodynamic classifications of PH?

A

1) increased pulmonary blood flow (CO)
2) increased pulmonary vascular resistance (PVR)
3) increased pulmonary venous pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is precapillary PH? What are it’s two main causes?

A

PH due to increased PVR in absence of increased PVP

  1. vasoconstriction
  2. structural pulmonary arterial changes due to pulmonary vascular disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is postcapillary PH?

A

PH due to increased PVP (= pulmonary venous hypertension)

  1. left sided heart disease
  2. increased LA pressure

–> ultimately increases the load the RV has to pump through the pulmonary circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some sequelae of chronic postcapillary PH?

A
  • pulmonary arterial vasoconstriction
  • pulmonary vascular disease

–> both increase PVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is “reactive” PH?

A

A combination of pre- and postcapillary PH secondary to chronic post-capillary PH due to severe left sided heart disease causing an increase in PVR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the effects of increased PVR and PAP on the RV?

A
  • increased RV afterload –> mixed hypertrophy (thickening + dilation)
  • Sustained high PAP –> RV dysfunction or failure

Clinical manifestation: R-CHF (elevated systemic venous pressures, pleural and/or abdominal effusion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are causes of stustained increases of pulmonary arterial pressure (PAP)?

A
  • Pulmonary artery (arteriolar) vasoconstriction
  • Pulmonary arterial remodeling/vascular disease
  • Increased pulmonary blood flow (e.g., left-to-right cardiac shunt, or chronically increased PVP from left-sided heart disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What causes increased PVP in left-sided heart disease?

A
  1. reactive vasoconstriction
  2. pulmonary vascular disease
    –> wall stiffening
    –> endothelial dysfunction
    –> vascular inflammation
    –> thrombosis
    –> fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What ist the gold standard for assessment of PH?

A

Right heart catheterization with direct assessment of PAP and pulmonary artery wedge pressure (surrogate of LA pressure) –> CO can be measured + PVR calculated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name 4 clinical findings strongly suggestive of PH

A
  1. Syncope (esp. exertion/excitement related)
  2. Respiratory distress at rest
  3. Activity/exercise terminating in respiratory distress
  4. R-CHF (aszites)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name 3 clinical findings possibly suggestive of PH

A
  1. Tachypnea at rest
  2. increased respiratory effort at rest
  3. Prolonged postexcercise/activity tachypnea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name 3 reasons for increased pulmonary blood flow

A
  1. left-to-right-shunt due to intra- or extracardiac defects (e.g. ASD, VSD, PDA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name 9 reasons for increased pulmonary vascular resistance

A
  1. Pulmonary arterial (arteriolar) vasoconstriction
  2. Pulmonary arterial thrombosis
  3. Pulmonary endothelial dysfunction
  4. Pulmonary vascular remodeling
  5. Perivascular inflammation
    P6. ulmonary vascular luminal obstruction
  6. Increased blood viscosity
  7. Pulmonary arterial wall stiffening
  8. Pulmonary parenchymal destruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name 2 reasons for increased pulmonary venous pressures

A
  1. Left heart disease (e.g., MMVD)
  2. Compression or stenosis of a large pulmonary
    vein(s)
17
Q

What 2 key components does echocardiography rely on for diagnosing PH?

A
  1. characteristic cardiac changes that occur secondary to PH (=echocardiographic signs of PH)
  2. estimates of systolic PAP using Doppler echocardiography
18
Q

Name 6 echocardiographic findings that are indicative of PH

A
  • RV hypertrophy
  • RV systolic dysfunction
  • LV underfilling
  • flattening of the interventricular septum
  • pulmonary artery dilation + altered blood flow profile
  • RA/caudal vena cava enlargement
19
Q

How can systolic PAP be estimated using echocardiography?

A
  1. quantifying peak tricuspid regurgitation velocity (TRV)
  2. conversion of TRV to a pressure gradient (between the RA and RV in systole) using the simplified Bernoulli equation
20
Q

What equation can be used to quantify systolic PAP on echo?

A

Simplified Bernoulli equation

21
Q

What is the simplified Bernoulle equation?

A

pressure gradient = 4x Velocity (m/s)^2

22
Q

How can the degree of PH be quantified using a pressure gradient betweent the RA and the RV?

A

mild: 30-50mmHg
moderate: 50-75mmHg
severe: >75mmHg

23
Q

What are is the clinical classifications scheme proposed by the ACVIM consensus guidelines for PH?

A

1) pulmonary arterial hypertension (PAH)
2) left-sided heart disease
3) respiratory disease/hypoxia
4) pulmonary thrombotic or thromboembolic disease (PT/PTE)
5) parasitic disease (heartworm or Angiostrongylus)
6) multifactorial (≥2 categories) or unclear mechanisms

24
Q

What 2 criteria must be met for PH to be classified as secondary to left-sided herat disease?

A

1) documentation of LHD
2) documentation of unequivocal LA enlargement (curde surrogate marker for elevated LA pressures)

25
What heart murmur is highly suggestive for PH in dogs with MMVD?
Murmur over tricuspid valve region
26
What are general recommendation for the management of PH?
1. treat underlying disease causing PH 2. oxygen supplementation 3. heartworm prevention 4. exercise restriction 5. avoiding air travel and high altitude (without oxygen supplementation)
27
What is the most common medication used to treat PH and what is its MOA?
Sildenafil (1–3 mg/kg PO TID) or tadalafil (2mg/kg SID - longer half-life) = Phosphodiesterase-5 inhibitor (PDE5i) --> inhibits cGMP catabolism --> accumulation of cGMP in pulmonary vascular smooth muscle cells --> relaxation of vascular smooth muscle + inhibition of pulmonary arterial smooth muscle cell hypertrophy --> lower PVR + potentially delaying adverse remodeling of pulmonary arteries
28
Why could the response to sildenafil be blunted in some dogs?
PDE5A gene polymorphism --> can blunt the effectiveness of sildenafil in dogs with PH
29
What are other medications proposed for management of PH?
* phosphodiesterase-3 inhibitors (pimobendan, milrinone) * tyrosine kinase inhibitors (toceranib, imatinib) * L-arginine --> currently not recommended
30
When is treatment with PDE5i indicated in PH in groups 1 and 3-5?
* clinical signs/findings suggestive of PH + intermediate or high echocardiographic probability of precapillary PH --> significant right heart remodeling, TRV is .3.4 m/s or both
31
What is possible complication of using PDE5i in dogs with PH secondary to left heart disease?
increased right cardiac output and venous return to LA --> Pulmonary edema
32
What is the treatment of PH in dogs with postcapillary PH?
first-line therapy is centered around decreasing LA pressure (e.g., furosemide, pimobendan) + management of heart failure
33
When is PDE5i treatment indicated in dogs with left-sided heart disease causing mixed PH?
* if dogs remain symptomatic following strategies to lower LA pressure * if left heart failure is well controlled (if initially present) * if right heart failure is present conservative dose: sildenafil 0.5 mg/kg PO q8h
34
Outline the treatment of PH in the critical care setting
* Oxygen therapy * PDE5i * hemodynamic resuscitation * meticulous fluid volume management to optimize the preload * +/- diureitcs to optimize blood volume + RV preload * consider positive inotropy in severe RV systolic dysfunction --> people: dobutamine CRI; risk: vasodilation --> hypotension --> alternative: norepinephrine CRI: increases SVR + RV contractility
35
What is the prognosis for dogs with PH?
variable and linked to the cause and severity of the underlying disease(s) causing the PH
36
What effect on prognosis has PH in dogs with MMVD and respiratory disease causing PH?
worsens the prognosis